Transpyloric Feeding for Prevention of Micro-aspiration
- Conditions
- MicroaspirationGastro Esophageal Reflux
- Interventions
- Other: Transpyloric feeding
- Registration Number
- NCT03646045
- Lead Sponsor
- Nemours Children's Clinic
- Brief Summary
To determine the effect of transpyloric (TP) feeding on microaspiration and lung inflammation in ventilated preterm infants.
- Detailed Description
Specific Aim 1): To determine the effect of TP feeding on microaspiration and lung inflammation. Hypothesis: TP feeding will reduce the microaspiration and pulmonary inflammation in ventilated preterm infants. Evaluate markers of microaspiration (pepsin A) and lung inflammation \[total cell counts, nuclear factor-kB (NF-kB) activation, tumor necrosis factor-α (TNF-α), IL-1β, IL-6, IL-8, angiopoietin 2 (Ang2), high-mobility group box-1 protein (HMGB1), macrophage migration inhibitory factor (MIF) and interferon-γ (IFN-γ)\] in TA samples obtained from preterm ventilated infants with and without TP feeding.
Specific Aim 2): To determine the effect of TP feeding on respiratory support. Hypothesis: TP feeding will decrease the respiratory severity score (RSS) \[Fraction of inspired oxygen (FiO2) X mean airway pressure (MAP)\] and number of infants requiring ventilator support. Evaluate respiratory support in preterm ventilated infants with and without TP feeding.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 46
- Preterm infants with birth weight <1500 grams
- Requiring ventilatory support
- Culture-proven sepsis
- Ventilator associated pneumonia (VAP).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Transpyloric feed Transpyloric feeding Preterm infant receiving transpyloric feeding.
- Primary Outcome Measures
Name Time Method Tracheal aspirate pepsin A levels in ventilated preterm infants receiving transpyloric feeding and gastric feeding. 3-7 days Difference in tracheal aspirate pepsin A levels in preterm ventilated infants receiving transpyloric feeding and gastric feeding.
- Secondary Outcome Measures
Name Time Method Respiratory support in ventilated preterm infants before and transpyloric feeding. 7-14 days Change in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants before and after transpyloric feeding.
Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants before and after transpyloric feeding. 3-7 days Change in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants before and after transpyloric feeding.
Tracheal aspirate pepsin A levels in ventilated preterm infants before and after transpyloric feeding. 3-7 days Change in tracheal aspirate pepsin A levels in preterm ventilated infants before and after transpyloric feeding.
Tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in ventilated preterm infants receiving transpyloric feeding and gastric feeding. 3-7 days. Difference in tracheal aspirate cytokines levels (TNF-α, IL-1β, IL-6, IL-8, Ang2, HMGB1, MIF and IFN-gamma) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.
Respiratory support in ventilated preterm infants receiving transpyloric feeding and gastric feeding. 7-14 days Difference in respiratory severity score (FiO2 X mean airway pressure) in preterm ventilated infants receiving transpyloric feeding and gastric feeding.
Trial Locations
- Locations (2)
Thomas Jefferson University Hospital
🇺🇸Philadelphia, Pennsylvania, United States
AI duPont Hospital for Children
🇺🇸Wilmington, Delaware, United States